09 October 2017 | Statement

Unitaid commits US $21.4 million to the WHO prequalification programme

Geneva – Unitaid is investing a further US$ 21.4 million in the World Health Organization’s (WHO) prequalification programme for medicines and diagnostics.

Unitaid has supported the prequalification programme for medicines since 2006 and for diagnostics since 2009. The decision, taken in July, to invest a further US$ 21.4 million increases the value of Unitaid’s total investment to date to over US$ 124 million. With around one third to be spent on diagnostics and two thirds on medicines, Unitaid’s support to WHO’s prequalification programme through to December 2018 will be used to cover activities related to HIV/TB/Malaria/HCV products specifically, with the following objectives:

For more on WHO’s Prequalification programme:

Check out the WHO website

Read more: Unitaid’s publications library on prequalification


View All News

Featured News

19 March 2018

Honouring Professor David Cooper

Read More

27 February 2018

WHO provides first-ever approval for rectal artesunate product for severe malaria

Read More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.